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Abstract: In the study, we have examined the antitumor and antimicrobial activities of the 
methanol extract, the fractions, a fraction of total alkaloids and two alkaloids isolated from 
the stem of Erythroxylum caatingae Plowman. All test fractions, except the hexane fractions, 
showed antimicrobial activity on gram-positive bacteria and fungi. The acetate: methanol 
(95:5),  acetate,  chloroform  and  hexane  fractions  show  the  highest  cytotoxicity  activity 
against the NCI-H292, HEp-2 and K562 cell lines using MTT. The absence of hemolysis  
in the erythrocytes of mice was observed in these fractions and 6β-Benzoyloxy-3α-(3,4,5-
trimethoxybenzoyloxy) tropane (catuabine B). Staining with Annexin V-FITC and JC-1 was 
used to verify  the mechanism of action of the  compounds of  E. caatingae that showed 
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cytotoxicity less than 30 μg/mL in leukemic cells. After 48 h of incubation, we observed that 
the acetate: methanol (95:5), acetate, and chloroform fractions, as well as the catuabine B, 
increased in the number of cells in early apoptosis, from 53.0 to 74.8%. An analysis of the 
potential of the mitochondrial membrane by incorporation of JC-1 showed that most cells 
during incubation of the acetate: methanol (95:5) and acetate fractions (63.85 and 59.2%) 
were stained, suggesting the involvement of an intrinsic pathway of apoptosis. 
Keywords: Erythroxylum caatingae; antimicrobial activity; cytotoxic activity; hemolytic 
activity; apoptosis 
 
1. Introduction 
The research with medicinal plants aiming at the development of phytotherapeutic medicines and 
the promotion of the rational use of these products by the populations of developing countries such as 
Brazil,  have  a  great  importance  not  only  in  socio-economic  aspects  but  also  because  they  enable  
a greater knowledge of the culture of such people and a better utilization of the biodiversity of the 
respective countries [1]. Approximately 25% of the medicines prescribed in the industrialized countries 
originate from plants and about 120 compounds of natural origin, obtained from approximately 90 species 
of plants, are used in modern therapy. In Brazil, approximately 80,000 species of plants are described, 
offering a wide range of raw material for the discovery of new drugs [2,3]. 
It is well established that plants have always been useful sources of antitumor or cancer prevention 
compounds [4–6]. Approximately more than 60% of currently-used anticancer chemotherapeutic drugs 
are derived in one way or another from natural sources, including plants [7,8]. The search for anticancer 
agents from plant sources began in the 1950s with the discovery and development of the vinca alkaloids, 
vinblastine  and  vincristine,  isolated  from  Catharanthus  roseus,  and  etoposide  and  teniposide,  the 
semisynthetic derivatives of epipodophyllotoxin, isolated from Podophyllum peltatum and P. endoii [7]. 
The  indiscriminate  use  of  antibiotics  has  led  to  antibiotic  resistance  in  many  pathogenic 
microorganisms and has led researchers to seek new antibiotics that are effective. Several alternatives 
have been suggested to solve this problem, such as the search for new antimicrobials in plant species [9]. 
Since the early 1980s, the number of drugs in development has decreased considerably, while the 
resistance of microorganisms, due to the constant use of antibiotics, has grown immensely. This is because 
series of new mechanisms of resistance are constantly being developed. The study of bacterial resistance is 
usually based on microorganisms  of epidemiological  significance, such as Staphylococcus  aureus, 
Escherichia coli, Pseudomonas aeruginosa and fungi, which are responsible for different etiological 
processes in both immunocompetent and immunosuppressed patients [10]. 
The Erythroxylaceae family comprises approximately 250 species distributed across four genera, 
Aneulophus Benth, Nectaropetalum Engl., Pinacopodium Exell and Mendonç a and Erythroxylum P. 
Browne [11,12]. The genus Erythroxylum consists of approximately 200 species, diversely distributed 
over  South  America,  Africa  and  the  island  of  Madagascar  [13,14].  It  has  been  used  in  many 
ethnomedical  practices  as  an  anti-inflammatory  agent,  an  antibacterial  agent  and  a  tonic  for  its 
stimulant properties and as a powerful diuretic for liver, renal and vesicular afflictions. Erythroxylum Int. J. Mol. Sci. 2012, 13  4126 
 
 
has  been used to  treat  venereal  diseases,  rheumatism,  arthrosis, respiratory  affections,  amenorrhea  
and  hemorrhages  [15,16].  In  Brazil,  the  family  is  represented  by  the  genus  Erythroxylum,  with 
approximately 114 species, and there are 13 species registered in state of Paraí ba [12]. 
The genus is characterized by the presence of tropane alkaloids, tannins, terpenes, flavonoids and 
phenylpropanoids [14,17]. Tropane alkaloids are an important class of natural products because of 
their analgesic, anesthetic, anticholinergic, antiemetic, antihypertensive, parasympatholytic, and other 
pharmacological properties [18]. 
The aim of the present study was to evaluate the antimicrobial and cytotoxic activities of the methanol 
extract fractions and two alkaloids isolated from the stem of Erythroxylum caatingae Plowman. For the 
evaluation  of  antimicrobial  activity,  the  following  fractions  were  tested  against  gram-positive  and  
gram-negative bacteria and against fungi: the acetate phase (AcOEt), various ratios of acetate: methanol 
[AcOEt:MeOH  (60:40);  AcOEt:MeOH  (80:20);  AcOEt:MeOH  (90:10)  and  AcOEt:MeOH  (95:5)], 
chloroform (CHCl3) and hexane (C6H6). Antiproliferative activity was tested against tumor cell lines 
(NCI-H292, human lung mucoepidermoid carcinoma cells, K562, chronic myelocytic leukemia, and 
HEp-2,  human  larynx  epidermoid  carcinoma  cells)  and  hemolytic  activity  was  measured  for the 
methanol extracts, its fractions and alkaloids. Another set of experiments was performed with K562, 
which was used to investigate the mechanisms involved in the antitumor activity of the fractions and 
the alkaloids of E. caatingae. 
2. Results and Discussion 
2.1. Antimicrobial Activity 
The antimicrobial activities of methanol extract, fractions from the stem of E. caatingae Plowman 
were tested using the disc diffusion method at a concentration of 2000 µg/disc. The results are presented 
in  Tables  1–3.  All  test  fractions,  except  the  hexane  fractions,  showed  antimicrobial  activity  on  
gram-positive  bacteria  and  fungi.  The  DMSO  (control)  did  not  produce  inhibition  haloes  against  
the microorganisms studied, indicating that this solvent does not interfere with the antimicrobial activity 
results for the extract or fractions. The bacteria that were the most sensitive to the fractions tested were  
Micrococcus luteus and Mycobacterium smegmatis, with each showing inhibition zones of 13.5 ±  0.7 
to  29.5  ±   0.7  mm  and  14.0  ±   1.4  to  31.5  ±   1.4  mm,  respectively.  The  AcOEt:MeOH  (80:20), 
AcOEt:MeOH (90:10), AcOEt:MeOH (95:5) and the CHCl3 phases showed significant inhibition zones 
of 18.0 ±  0.0 to 19.0 ±  1.4 mm for Candida albicans (Table 1). Evaluation of the minimum inhibitory 
concentration  of  the  extract  and  fractions  of  E.  caatingae  (zone  of  inhibition  >  12  mm)  showed 
significant inhibitory concentrations for S. aureus, M. luteus, B. subtilis, M. smegmatis, E. faecalis and 
C. albicans. However, the lowest values of the minimum inhibitory concentration (MIC) and minimum 
bacteriostatic concentration (MBC) against M. luteus went to the AcOEt:MeOH (95:5), AcOEt:MeOH 
(90:10) and CHCl3 fractions (Tables 1–3). 
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Table 1. Antimicrobial activity of the methanol extract of the stem of Erythroxylum caatingae 
and of its fractions (2000 µg/disc). 
Microorganisms 
Zone of Inhibition (mm) 
1  2  3  4  5  6  7  8 
Kanamicin 
(30 µ g/disc) 
ketoconazole 
(300 µg/disc) 
S. aureus  10.5 ±  0.7  10.0 ±  0.0  11.0 ±  0.7  12.0 ±  0.0  12.0 ±  0.0  0.0  10.5 ±  0.7  0.0  28  - 
M. luteus  21.5 ±  2.1  26.0 ±  1.4  28.5 ±  0.7  28.5 ±  0.7  29.5 ±  0.7  13.5 ±  0.7  26.0 ±  0.0  0.0  34  - 
B. subitilis  10.0 ±  0.0  10.0 ±  0.0  13.5 ±  0.7  13.5 ±  0.7  13.0 ±  0.7  0.0  12.0 ±  0.0  0.0  29  - 
M. smegmatis  14.0 ±  1.4  22.5 ±  0.7  30.0 ±  0.0  31.5 ±  1.4  30.0 ±  0.0  15.0 ±  0.0  15.0 ±  0.0  0.0  40  - 
E. faecalis  0.0  0.0  11.5 ±  0.7   11.5 ±  0.7  12.5 ±  0.7  0.0  17.0 ±  0.0  0.0  13  - 
E. coli  0.0  0.0  0.0  0.0  0.0  0.0  0.0  0.0  15  - 
S. marcescens  0.0  0.0  0.0  0.0  0.0  0.0  0.0  0.0  15  - 
P. aeruginosa  0.0  0.0  0.0  0.0  0.0  0.0  0.0  0.0  20  - 
C. albicans  0.0  0.0  19.0 ±  1.4  19.0 ±  1.4  18.0 ±  1.4  0.0  18.0 ±  0.0  0.0  -  24 
1: Methanol extract of stem of E. caatingae (MEEC); 2: AcOEt:MeOH (60:40); 3: AcOEt:MeOH (80:20); 4: AcOEt:MeOH 
(90:10); 5: AcOEt:MeOH (95:5); 6: AcOEt; 7: CHCl3; 8: Hexane fraction. Data are presented as the mean ±  SD of two 
independent experiments. Each experiment was done in triplicate. 
Table 2. Evaluates the minimum inhibitory concentration of the methanol extract of the 
stem of Erythroxylum caatingae and of its fractions. 
Microorganisms 
Minimum Inhibitory Concentration (µ g/mL) 
1  2  3  4  5  6  7 
S. aureus  n.t.  n.t.  n.t.  250  250  n.t.  n.t. 
M. luteus  250  250  n.t.  <31.25  <31.25  250  <31.25 
B. subtilis  n.t.  n.t.  n.t.  250  250  n.t.  125 
M. smegmatis  500  500  n.t.  125  125  1000  125 
E. faecalis  n.t.  n.t.  n.t.  n.t.  500  n.t.  500 
C. albicans  n.t.  n.t.  n.t.  250  125  n.t.  125 
1: Methanol extract of stem of E. caatingae (MEEC); 2: AcOEt:MeOH (60:40); 3: AcOEt:MeOH (80:20);  
4: AcOEt:MeOH (90:10); 5: AcOEt:MeOH (95:5); 6: AcOEt; 7: CHCl3; n.t.: not tested. Each experiment was 
done in triplicate. 
Table 3. Evaluates the minimum bacteriostatic concentration of the methanol extract of the 
stem of Erythroxylum caatingae and of its fractions. 
Microorganisms 
Minimum Bacteriostatic Concentration (µ g/mL) 
1  2  3  4  5  6  7 
S. aureus  n.t.  n.t.  n.t.  1000  500  n.t.  n.t. 
M. luteus  250  500  n.t.  <31.25  <31.25  >2000  <31.25 
B. subtilis  n.t.  n.t.  n.t.  1000  500  n.t.  250 
M. smegmatis  1000  1000  n.t.  500  250  1,000  250 
E. faecalis  n.t.  n.t.  n.t.  n.t.  1000  n.t.  1000 
C. albicans  n.t.  n.t.  n.t.  500  500  n.t.  250 
1: Methanol extract of stem of E. caatingae (MEEC); 2: AcOEt:MeOH (60:40); 3: AcOEt:MeOH (80:20);  
4: AcOEt:MeOH (90:10); 5: AcOEt:MeOH (95:5); 6: AcOEt; 7: CHCl3; n.t.: not tested. Each experiment was 
done in triplicate.  Int. J. Mol. Sci. 2012, 13  4128 
 
 
Plants  are  an  important  source  of  potentially  useful  structures  for  the  development  of  new 
chemotherapeutic agents. The first step to identification of new chemotherapeutic agents is through 
trials  of  antibacterial  activity  in  vitro.  Many  reports  are  available  on  the  antiviral,  antibacterial, 
antifungal,  anthelmintic,  antimolluskal  and  anti-inflammatory  properties  of  plants.  Some  of  these 
observations have proven helpful in the identification of the active principle compounds responsible 
for such activities and in the development of drugs for therapeutic use in humans [19]. 
There are a few reports of the antimicrobial activity of the genus Erythroxylum. Among them, we 
highlight the alkaline extract of the bark of Erythroxylum catuaba that has been shown to have a protective 
action against lethal infections of E. coli and S. aureus [20]. However, Rahman et al. (1998) [21] reported 
the  absence  of  antibacterial  activity  against  S.  aureus,  E.  coli,  B.  subtilis  and  P.  aeruginosa  at  the 
concentrations of 100 and 200 μg/mL and the presence of antifungal activity of the alcoholic extract of 
Erythroxylum moonii against C. albicans. In our study, the absence of any antimicrobial activity of  
E. caatingae against S. aureus, P. aeruginosa and E. coli was also verified, while the AcOEt:MeOH 
(80:20), AcOEt:MeOH (90:10), AcOEt:MeOH (95:5) and the CHCl3 fractions inhibited the growth of 
C.  albicans.  However,  the  lowest  values  of  MIC  and  MBC  went  to  the  AcOEt:MeOH  (90:10), 
AcOEt:MeOH (95:5) and chloroform fractions against M. luteus. It was observed from the data that the 
most active fractions were more polar, probably due to the presence of phenolic compounds such as 
flavonoids or tannins. According Haslan (1996) [22], the antimicrobial activity exhibited by tannins is 
explained by the ability of these compounds present in complexing with macromolecules, such as 
polysaccharides and proteins present in bacteria. 
2.2. Cytotoxicity Activity 
The cytotoxicity of the 11 samples, including the extract, fractions and two isolated compounds on the 
human tumor cell lines were evaluated after 72 h using MTT, and the results are presented in Table 4. 
The AcOEt:MeOH (95:5) (5), AcOEt (6), CHCl3 (7) and C6H6 (8) fractions were the most cytotoxic 
against the NCI-H292, HEp-2 and K562 cell lines. The most sensitive strains tested were the HEp-2 
cell line, with an IC50 value equal to 8.25 ±  0.36 µg/mL for the CHCl3 fraction, and the K562 cell line, 
with an IC50 value equal to 13.10 ±  0.63 µg/mL, 9.86 ±  0.56 µg/mL and 11.21 ±  0.46 µg/mL for the 
AcOEt:MeOH (95:5), AcOEt and CHCl3 fractions, respectively. To verify whether the cytotoxicity 
observed was  related to the injury of the cell plasma membrane,  fractions 3–8  (Table 4) and the 
Catuabine B of E. caatingae were tested in the erythrocytes of mice (Mus musculus). The absence of 
hemolysis was observed in all substances. 
Table 4. Cytotoxic and hemolytic activity de Erytroxylum caatingae. 
Products/Extracts 
Cell Line, IC50 (µg/mL) 
EC50 (µg/mL) 
HEp-2  NCI-H292  K562 
1  50  50  50  n.t. 
2  50  50  50  n.t. 
3  50  25.76 ±  1.71  50  >2000 
4  50  25.50 ±  1.08  50  >2000 
5  40.59 ±  0.72  28.19 ±  2.09  13.10 ±  0.63  >2000 
6  34.12 ±  1.01  20.37 ±  0.75  9.86 ±  0.56  403.24 ±  9.64 Int. J. Mol. Sci. 2012, 13  4129 
 
 
Table 4. Cont. 
Products/Extracts 
Cell Line, IC50 (µ g/mL) 
EC50 (µ g/mL) 
HEp-2  NCI-H292  K562 
7  8.25 ±  0.36  34.39 ±  1.71  11.21 ±  0.46  1036.52 ±  35.17 
8  31.42 ±  1.01  15.79 ±  1.01  33.58 ±  1.33  510.00 ±  8.60 
9  50  50  50  n.t. 
10  50  50  9.36 ±  0.77  >250 
11  50  50  50  n.t. 
Etoposide  6.10 ±  0.19  2.75 ±  0.10  4.48 ±  0.23  n.t. 
1: Methanol extract of stem of E. caatingae (MEEC); 2: AcOEt:MeOH (40:60); 3: AcOEt:MeOH 
(80:20);  4:  AcOEt:MeOH  (90:10);  5:  AcOEt:MeOH  (95:5);  6:  acetate  fraction  (AcOEt);  
7: chloroform fraction (CHCl3); 8: hexane fraction (C6H6); 9: Fraction total of alkaloids; 10: catuabine 
B;  11:  3α,6β-dibenzoyloxytropane;  n.t.:  not  tested. The  IC50  and  EC50  and  its  95% confidence 
interval (CI 95%) were obtained by non-linear regression. Data are presented as mean ±  SD of two 
independent experiments. Each experiment was done in triplicate. 
The cytotoxic activity of Erytroxylum in carcinoma and adenocarcinoma cells was first described by 
Silva et al. (2001) [15]. This study showed that the methanolic extract and alkaloids of tropanes of 
Erytroxylum pervillei inhibited the growth of KB-V1 cells (human cervix carcinoma multidrug-resistant 
cells) in the presence of vinblastine and were much less cytotoxic to KB-V1 cells in the absence of 
vinblastine or KB cells (oral squamous cell carcinoma). The alkaloids of the species pervillene B and  
C showed cytotoxic activity in adenocarcinomas of ovary (SKOV3) cells and in adenocarcinomas of 
multidrug-resistant  ovary  (SKVLB)  cells  incubated  with  adriamycin.  The  following  year,  alkaloids 
isolated from the stem of Erytroxylum rotundifolium were also found to be cytotoxic in KB-V1 cells [23]. 
Extracts  of  Erytroxylum  minutifolium  and  Erytroxylum  confusum  produced  a  significant  
cytotoxic effect in rat hepatocytes and displayed hepatoprotective, anti-inflammatory and antimicrobial 
activities [24,25]. 
Among the few reports of cytotoxicity of the genus Erythroxulum, our group found an absence  
of cytotoxicity in the methanol extract of E. caatingae stems and in the catuabine B against human 
cancer cell lines (HEp-2, NCI-H292 and KB) of cytotoxicity within in the tested concentration range 
of  50.0–1.56  µg/mL  [26].  However,  this  cytotoxicity  test  showed  that  the  AcOEt:  MeOH  (95:5), 
AcOEt, CHCl3 and hexane fraction were the most active against the HEp-2, NCI-H292 and K562 cell 
lines. The extracts showed promising activity, with IC50 values ranging between 8.2–40.5 μg/mL. Most 
of these values were within the cutoff point of the National Cancer Institute criteria for cytotoxicity 
(IC50 < 30 μg/mL) in the screening of crude plant extracts, which indicates that these extracts are 
promising for further purification and study [27]. 
Although we observed cytotoxic activity, the E. caatingae extracts and fraction did not possess any 
activity against the mouse erythrocytes. These data suggest that the cytotoxic activity was not related 
to the lytic properties or the membrane instability induced by the extracts. 
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2.3. Study of the Mechanisms of Action of the Phases of Erythroxylum caatingae 
2.3.1. Annexin/PI Cell Death Assay 
K562 cells incubated with the AcOEt:MeOH (95:5) (5), acetate (6) and CHCl3 fractions (7) and the 
catuabine B (10) were evaluated with the Annexin V-FITC kit by fluorescent microscopy to verify that 
cell  death  was  induced  by  apoptosis  through  the  externalization  of  phosphatidylserine.  The  doses 
chosen for the test were equal to the IC50 values. After 48 h of incubation, we observed that the 
AcOEt:MeOH (95:5) (13 µg/mL), AcOEt (9.8 µg/mL) and CHCl3 (11.2 µg/mL) fractions, as well as the 
catuabine B alkaloid (10 µg/mL), all increased the number of cells in early apoptosis (Ann V
pos/PI
neg) 
by 53.0%, 74.8%, 61.7% and 65.0%, respectively, when compared to the control. These substances 
exhibited values less than 1% of late apoptotic cells (AnnV
pos/PI
pos) and values less than 8% of cells in 
necrosis (AnnV
neg/PI
pos) (Figures 1 and 2). 
Figure 1. Effect of AcOEt:MeOH (95:5) (5), AcOEt (6), CHCl3 (7) and Catuabine B (10) 
in K562 cell population determined by fluorescence microscopy using Annexin V—FITC 
Kit, after 48 h incubation. The negative control (C) was the vehicle used for diluting the 
tested substances. Etoposide (E) was used as positive control. * p < 0.01 compared to 
control  by  ANOVA,  followed  by  Newman-Keuls  multiple  comparison  test.  Data  are 
presented as mean ±  SD from three independent experiments. 
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Figure  2.  AnnV/PI  staining  of  the  cells.  An  image  of  K562  showing:  (A)  viable 
(AnnV
neg/PI
neg); (B) early apoptotic (AnnV
pos/PI
neg); (C) late apoptotic (AnnV
pos/PI
pos) and 
(D) necrotic (AnnV
neg/PI
pos) cell. 
 
Apoptosis is currently a subject of research interest, in part because tumor cells are susceptible to 
death by apoptosis in response to various drugs used in chemotherapy [28]. 
Apoptosis  is  regulated  by  two  major  pathways:  the  extrinsic  (receptor  mediated)  and  intrinsic 
(mitochondrial mediated) pathways. Due to the sensitivity of the intrinsic pathway, tumors arise more 
often through this pathway than through the extrinsic pathway [29]. The extrinsic pathway involves 
execution through cell surface death receptors, recruiting the Fas-associated death domain, which leads 
to the activation of caspase-8 [30]. The intrinsic pathway requires a loss/disruption of the mitochondrial 
membrane potential in the cells, which eventually may cause the initiation and activation of apoptotic 
cascades.  The  cascade  triggers  the  release  of  cytochrome  c  and  other  apoptogenic  molecules,  such  
as Smac/DIABLO, from the mitochondria to the cytosol. Once in the cytosol, cytochrome c binds to  
Apaf-1 and recruits and activates caspase-9 in the apoptosome. Active caspase-9 cleaves and activates 
caspase-3, the caspase required to complete the induction of apoptosis [31]. Therefore, we sought to 
determine  whether  the  phases  that  induced  apoptosis  were  associated  with  the  disruption  of  the 
mitochondrial membrane potential in K562 cells. As shown in Figure 2A, the treatment of K562 cells Int. J. Mol. Sci. 2012, 13  4132 
 
 
with the AcOEt:MeOH (95:5) (13 µg/mL), AcOEt (9.8 µg/mL) and CHCl3 fraction (11.2 µg/mL), as 
well as the catuabine B for 48 h resulted in an increase in the number of cells in early apoptosis by 
53.0, 74.8, 61.6 and 65.0%, respectively. These data show that the main mechanism of cell death 
caused by the extracts is apoptosis, which suggests the involvement of the intrinsic pathway. 
2.3.2. Measurement of the Mitochondrial Membrane Potential 
To investigate the possible involvement  of the  mitochondrial pathway in apoptosis  induced  by  
the products under study, the analysis of the mitochondrial membrane potential by the incorporation of 
JC-1 was evaluated by fluorescence microscopy. The doses chosen for the test were equal to the IC50 
values.  After  48  h  of  incubation,  we  observed  that  the  AcOEt:MeOH  (95:5),  AcOEt  and  CHCl3 
fractions, as well as the catuabine B (10), all showed 63.8%, 59.2%, 50.0% and 27.2% apoptotic cells, 
respectively (Figures 3 and 4). 
Figure 3. Effect of AcOEt:MeOH (95:5) (5), AcOEt (6), CHCl3 (7) and catuabine B (10) 
in K562 cell population determined by fluorescence microscopy using JC-1, after 48 h 
incubation. The negative control (C) was the vehicle used for diluting the tested substances. 
Etoposide (E) was used as positive control. * p < 0.01 compared to control by ANOVA, 
followed by Newman-Keuls multiple comparison test. Data are presented as mean ±  SD 
from three independent experiments. 
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Figure 4. JC-1 staining of the cells. An image of K562 showing: (A) Green fluorescence 
emitted by cells is attributed to depolarized mitochondrial membrane; (B) No depolarized 
mitochondrial membrane emits red fluorescence. 
 
To confirm the involvement of the intrinsic pathway in cell death induced by treatment with the 
fractions and the alkaloids isolated from E. caatingae, an analysis of the mitochondrial membrane 
potential was made by the incorporation of JC-1. Cells treated with the AcOEt:MeOH (95:5), AcOEt, 
and CHCl3 fractions, as well as the catuabine B for 48 h, resulted in an increase in the number of green 
fluorescence-positive cells of 63.8, 59.2, 50.0, and 27%, respectively, thus, confirming the disruption 
of the mitochondrial membrane potential on treatment. 
The  intrinsic  pathway  requires  the  disruption  of  the  mitochondrial  membrane  and  the  release  
of mitochondrial proteins, such as cytochrome c, which work together with the other two cytosolic 
protein  factors,  Apaf-1  (apoptotic  protease  activating  factor-1)  and  procaspase-9,  to  promote  the 
assembly of the caspase-activating complex (termed the apoptosome), which in return induces the 
activation  of  caspase-9  and  initiates  the  apoptotic  caspase  cascade  [32,33].  In  our  study,  the 
AcOEt:MeOH (95:5), AcOEt, and CHCl3 fractions showed death by apoptosis, which mainly involved 
the mitochondrial pathway, especially with the acetate fraction. 
3. Experimental Section 
3.1. Chemicals 
Phosphate buffered saline (PBS), penicillin-streptomycin liquid and DMEM (Dulbecco’s Modified 
Eagle’s Medium) were purchased from Gibco. MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium  bromide)  was  purchased  from  Invitrogen.  Eposide  (Etoposide)  was  purchased  from 
Blausiegel. Fetal bovine serum (FBS), glutamine, Triton X-100 and JC-1 (5,5′,6,6′-Tetrachloro-1,1′, 
3,3′-tetraethylbenzimidazolcarbocyanine  iodide)  were  purchased  from  Sigma-Aldrich  Brazil.  The 
Annexin  V-FITC  Apoptosis  Detection  Kit  was  purchased  from  Calbiochem.  DMSO  (Dimethyl 
sulfoxide), CaCl2, NaCl, and paraformaldehyde were purchased from Vetec. Mueller Hinton Agar and 
Sabouraud were purchased from Difco, and kanamycin and ketoconazole were purchased from Cecon. 
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3.2. Plant Material 
The  stems  of  Erythroxylum  caatingae  Plowman  were  collected  in  Picuí ,  Paraí ba,  Brazil.  The 
botanical  material  was  identified  by  Maria  de  Fá tima  Agra  of  the  Laboratory  of  Pharmaceutical 
Technology, Federal University of Paraí ba. A dried specimen was deposited in the herbarium of Lauro 
Pires Xavier (JPB) of the Federal University of Paraí ba under the identification label AGRA 5666. 
3.3. Extraction and Isolation 
The crude methanol extract (500 g) was dissolved in water and defatted with C6H6. The defatted 
aqueous extract was acidified with 3% HCl with mechanical mixing and filtered through Celite, which 
yielded a residue, which was discarded, and an acidic solution. The acidic solution was extracted with 
CHCl3 (3 ×  500 mL), which resulted in an acid chloroform phase and an aqueous phase that was 
neutralized to pH 7.0 with ammonium hydroxide. The aqueous phase, at pH 7.0, was extracted with 
CHCl3 to yield an aqueous phase and the basic chloroform phase (4.0 g), which was submitted to 
column chromatography (CC) using a silica gel as the stationary phase and CHCl3 and MeOH as the 
eluents, which were used either independently or in binary mixtures with increasing polarity. The 
result was 55 fractions of 100 mL. The 55 fractions were monitored by thin layer chromatography 
(TLC) and eluted with various solvent systems (CHCl3 and/or CHCl3-MeOH in order of increasing 
polarity)  in  chambers  that  were  pre-saturated  with  NH3  vapor.  They  were  then  revealed  with 
Dragendorff’s reagent and placed in 21 groups based on their Rf. Fraction 25, 45 and 46 were submitted 
to repeated recrystallization with acetone and ether to obtain alkaloids. The elucidation of the chemical 
structures was described by Oliveira et al. (2011) [26]. 6β-Benzoyloxy-3α-(3,4,5-trimethoxybenzoyloxy) 
tropane  (Catuabine  B)  and  3α,6β-dibenzoyloxytropane  were  also  isolated.  The  extract  and  fractions 
obtained  were  evaporated  until  dry.  The  following  extracts  were  all  tested:  the  methanol  extract  
of  the  stem  of  E.  caatingae  (MEEC)  and  the  AcOEt:MeOH  (60:40),  AcOEt:MeOH  (80:20), 
AcOEt:MeOH (90:10), AcOEt:MeOH (95:5), AcOEt, CHCl3, and the hexane fractions, as well as the 
total alkaloids fraction. 
3.4. Microorganisms 
The  microorganisms,  which  were  from  the  Antibiotics  Department  collection  of  the  Federal 
University of Pernambuco were as follows: S. aureus, UFPEDA 01; Bacillus subtilis, UFPEDA 16; 
Enterococcus faecalis, UFPEDA 138; Micrococcus luteus, UFPEDA 06; Escherichia coli, UFPEDA 
224; P. aeruginosa, UFPEDA 39; Serratia marcescens, UFPEDA 398; Mycobacterium smegmatis, 
UFPEDA  71;  and  Candida  albicans,  UFPEDA  1007,  and  these  were  used  in  the  antimicrobial  
activity assays. 
3.5. Cell Lines and Cell Culture 
The  cell  lines  used  for  the  in  vitro  cytotoxicity  tests  were  K562  (human  chronic  myelocytic 
leukemia),  NCI-H292  (human  lung  mucoepidermoid  carcinoma  cells)  and  HEp-2  (human  larynx 
epidermoid carcinoma cells), and these were obtained from the Adolph Lutz Institute (Sã o Paulo, Int. J. Mol. Sci. 2012, 13  4135 
 
 
Brazil). The cells were maintained in DMEM supplemented with 10% fetal bovine serum, 2 mM 
glutamine, 100 U/mL penicillin, and 100 µ g/mL streptomycin at 37 ° C with 5% CO2. 
3.6. Animals 
Three Swiss mice (female, 25–30 g), obtained from the central animal house of the Universidade 
Federal de Pernambuco, Brazil, were used. The animals were housed in cages with free access to food 
and water. All animals were kept under a 12 h light:12 h dark cycle (lights on at 6:00 a.m.). The animals 
were treated according to the ethical principles of animal experimentation of the Brazilian College of 
Animal  Experimentation  (COBEA),  Brazil.  The  Animal  Studies  Committee  of  the  Universidade 
Federal do Pernambuco approved the experimental protocols (Number 23076.012173/2007-77). 
3.7. Antimicrobial Activity 
Antimicrobial activity was verified in vitro by the method of diffusion in paper record [34]. The 
microorganisms were standardized with an optical density of McFarland 0.5 in physiological solution [35], 
which corresponds to a concentration of approximately 10
7 UFC/mL for yeast and filamentous fungi and 
10
8 UFC/mL  for bacteria.  On the inoculated medium, Mueller  Hinton  Agar (S. aureus, B. subtilis,  
M.  luteus,  E.  coli,  P.  aeruginosa  and  S.  marcescens),  glucose  extracts  of  yeast  (E.  faecalis, 
M. smegmatis) and Sabouraud (C. albicans), and discs of barren paper (6 mm) were absorbed with  
10 µL of the solution 200,000 µg/mL of the methanol extract from the stem of E. caatingae and its 
fractions and were placed on the agar. After placing the discs, the plates were incubated for 24 h and  
48  h  at  30  ° C  and  35  ° C,  respectively.  The  antibiotics  kanamycin  and  ketoconazole  were  used  as 
standards at 30 µg/disc and 300 µg/disc, respectively. 
The Minimum Inhibitory Concentration (MIC) and Minimum Bacteriostatic Concentration (MBC) 
were applied to the substances that showed halos larger than 12 mm by serial dilutions in half-solids [36]. 
Aliquots of different volumes (0.03–1.0 mL) of the solutions at 20.000 µ g/mL were placed in Petri 
dishes and homogenized with 10 mL of the appropriate culture medium. The microorganisms were 
streaked on the surface of the medium, and the plates were incubated at 35 °C  and 30 °C  for 24 h and 
48 h, respectively. For values over 1000 μg/mL, the extract was considered inactive [37]. 
3.8. Cell Viability Assay (MTT Assay) 
The cytotoxicity of the methanol extract of the stems of E. caatingae and its fractions were tested 
against the K562, NCI-H292 and HEp-2 tumor cell lines. For these experiments, the cells were plated 
in 96-well plates (10
5 cells/mL for adherent cells or 0.3 ×  10
6 cells/mL for suspended cells). After 24 h, 
the extracts, fractions (6.25–50 µg/mL) and alkaloids (1.25–10 µg/mL) dissolved in DMSO were added 
to each well and incubated for 72 h. Control groups received DMSO (0.2%) in DMEN. Etoposide  
(1.25–20 µ g/mL) was used as  a positive  control. The  growth of the tumor cells was quantified by  
the  ability  of  the  living  cells  to  reduce  yellow  tetrazolium  MTT  (3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide) to a blue formazan product [38,39]. At the end of the 72 h incubation 
period, MTT (5.0 mg/mL) was added to the plate. After three hours for the suspended cells or two 
hours for the adherent cells, the formazan product from the reduction of MTT was dissolved in DMSO, Int. J. Mol. Sci. 2012, 13  4136 
 
 
and the absorbance was measured using a multi-plate reader. The effect of the drug was quantified as 
the percentage of control absorbance the reduced dye at 450 nm (Multi-plate Reader Thermoplate). 
3.9. Hemolytic Assay 
The hemolytic assay was performed in 96-well plates, following the method previously described 
by Costa-Lotufo et al. (2005) [40]. Each well received 100 µL of a 0.85% NaCl solution containing  
10 mM CaCl2. The first well served as the negative control and only contained the vehicle (10% DMSO). 
The second well contained 100 µL of the test substance that was diluted 1:2. The extracts were tested at 
concentrations ranging from 15.62 to 2000 µg/mL. The serial dilution continued until the 11th well. 
The last  well received 20 µL of 0.1% Triton X-100 (in 0.85% saline) to  obtain 100% hemolysis 
(positive control). Each well received 100 µL of a 2% suspension of mouse erythrocytes in 0.85% 
saline containing 10 mM CaCl2. After incubation at room temperature for 30 min and centrifugation, 
the supernatant was removed, and the released hemoglobin was measured by spectroscopic absorbance 
at 450 nm. Extracts with an EC50 value lower than 200 µg/mL were considered to be active. 
3.10. Analysis of the Mechanisms Involved in the Cytotoxic Activity 
The following experiments were performed to elucidate the mechanisms involved in the cytotoxic 
activity of the fractions and alkaloids on K562 cells after 48 h of incubation. 
3.10.1. Annexin/PI Cell Death Assay 
Cellular  apoptosis  was  stained  with  Annexin  V  and  propidium  iodide  (PI)  using  an  Annexin  
V—FITC kit (Calbiochem) following the protocol provided by the manufacturer. The suspension of 
K562 cells (0.3 ×  10
6 cells/mL) was seeded into 96-well plates. The plates were incubated at 37 °C  
with 5% CO2 for 24 h. After this period, the fractions and alkaloids that presented cytotoxicity were 
added at the concentration that was equal to the IC50 value. After 48 h of treatment, the cells were 
stained  with  Annexin  V  and  PI  following  the  manufacturer’s  recommended  protocol  and  were 
analyzed by an epifluorescence microscope (Carl Zeiss, Gö ttingen, Germany) at 1000×  magnification 
under an oil immersion with an emission filter of LP 515 nm and excitation filter of BP 450–490 nm. 
A minimum of 200 cells were counted in each sample. 
3.10.2. Measurement of the Mitochondrial Membrane Potential 
Mitochondrial depolarization was evaluated by the incorporation of JC-1. This assay was performed 
as previously described, with some modifications [41,42]. The JC-1 probe is freely permeable to cells 
and undergoes reversible transformation from a monomer to an aggregate form (Jagg). The suspension 
of K562 cells (0.3 ×  10
6 cells/mL) was seeded into 96-well plates. The plates were incubated at 37 °C  
and 5% CO2 for 24 h. The fractions that presented cytotoxicity were added at a final concentration 
equal to the IC50 value. After 48 h of treatment, 50 µL was collected, incubated with JC-1 (0.15 mM  
in DMSO) for 10 min in the dark and then washed twice with PBS. The cells were fixed with 4% 
paraformaldehyde, mounted on a glass slide and observed under an epifluorescence microscope (Carl 
Zeiss, Gö ttingen, Germany) with 1000×  magnification under an oil immersion with an emission filter Int. J. Mol. Sci. 2012, 13  4137 
 
 
of LP 515 nm and an excitation filter of BP 450–490 nm. A minimum of 200 cells were counted in each 
sample. The cells stained in red were classified as having a high potential mitochondrial membrane, 
while those stained in green were classified as having a low potential membrane. 
3.11. Statistical Analysis 
Data are presented as the mean ±  S.D. The IC50 and EC50 values and their 95% confidence intervals 
were  obtained  by  nonlinear  regression  using  SigmaPlot  11.0  (version  11.0.1;  Systat  Software  Inc.: 
Chicago, IL, USA, 2011). The differences between the experimental groups were compared by one-way 
analysis of variance (ANOVA), followed by Newman-Keuls test; the significance level was set at 1%. 
4. Conclusions 
According to the results of investigations, methanol extract of the stem of Erythroxylum caatingae 
and all tested fractions, except the hexane fraction, showed antimicrobial activity on gram-positive 
bacteria  and  fungi.  The  absence  of  hemolysis  in  the  erythrocytes  of  mice  was  observed  in  these 
fractions and 6β-Benzoyloxy-3α-(3,4,5-trimethoxybenzoyloxy) tropane (catuabine B). We observed 
that the acetate:methanol (95:5), acetate, and chloroform fractions, as well as the catuabine B induced 
apoptosis in K562 cells. An analysis of the potential of the mitochondrial membrane by incorporation 
of JC-1 showed that most cells during incubation of the acetate:methanol (95:5) and acetate phases 
were stained, suggesting the involvement of an intrinsic pathway of apoptosis. 
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